Historical returns of Enliven Therapeutics, - Common Stock (id:7856 ELVN)
Annual returns
| 2021 | 2022 | 2023 | YTD | |
|---|---|---|---|---|
| Enliven Therapeutics, Inc. - Common Stock | -89.80 % | 80.18 % | 234.70 % | 76.80 % |
| United States | 93.58 % (3236, Country_ID:6) | 1,141.30 % (3606, Country_ID:6) | 186.74 % (3640, Country_ID:6) | 28.13 % (3658, Country_ID:6) |
Trailing returns
| 1D | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | |
|---|---|---|---|---|---|---|---|---|---|---|
| Enliven Therapeutics, Inc. - Common Stock | -3.76 % | 0.988 % | -16.42 % | 3.28 % | 76.80 % | 133.49 % | 96.18 % | 0.000 % | 0.000 % | 0.000 % |
| All United States stocks | 2.11 % | 3.68 % | 7.70 % | 14.26 % | 26.98 % | 46.35 % | -3.33 % | 5.71 % | 3.31 % | 6.91 % |
Monthly returns
| January | February | March | April | May | June | July | August | September | October | November | December | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 |
13.11 %
|
1.91 %
|
8.85 %
|
-1.42 %
|
27.66 %
|
1.13 %
|
12.59 %
|
-16.81 %
|
17.97 %
|
8.37 %
|
|
|
76.80 % |
2023 |
11.73 %
|
368.26 %
|
3.25 %
|
-12.06 %
|
-3.48 %
|
10.26 %
|
-7.11 %
|
-17.14 %
|
-12.55 %
|
-9.30 %
|
-7.33 %
|
24.46 %
|
234.70 % |
2022 |
-38.77 %
|
10.95 %
|
23.68 %
|
-27.96 %
|
-10.37 %
|
5.17 %
|
-1.68 %
|
2.61 %
|
96.55 %
|
92.21 %
|
-4.91 %
|
-1.68 %
|
80.18 % |
2021 |
-40.98 %
|
-5.05 %
|
-34.06 %
|
-12.84 %
|
-2.02 %
|
7.05 %
|
-31.60 %
|
-11.30 %
|
-15.35 %
|
-11.33 %
|
-8.40 %
|
-32.84 %
|
-89.80 % |
Avg |
-13.73 %
|
94.02 %
|
0.43 %
|
-13.57 %
|
2.95 %
|
5.90 %
|
-6.95 %
|
-10.66 %
|
21.65 %
|
19.99 %
|
-6.88 %
|
-3.35 %
|
130.56 % |